Form D Explorer
BioLattice Ophthalmics, Inc, · CIK 2125596

Report a data issueCitable research briefCompare issuerPrivate research collection

BioLattice Ophthalmics, Inc,

CIK 2125596 · Corporation · Inc. DELAWARE · Philadelphia, Pennsylvania · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filings
2
Original notices
1
Amendments
1
Activity
Mar 30, 2026
through Oct 28, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMar 30, 2026 · DOct 28, 2026 · D/ALater minus earlier
Reported offering amount$2,500,000$3,310,000$810,000
Reported amount sold$575,000$1,825,000$1,250,000
Reported investor count—7—
Reported minimum investment$0$0$0

Earlier SEC source: 0002125596-26-000001 · Later SEC source: 0002125596-26-000003

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Oct 28, 2026

Reported offering amount
$3,310,000
Reported exemptions
Rule 506(b)
Reported amount sold
$1,825,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Form D filings (2)